...
首页> 外文期刊>Annals of Dermatology >A Case of Bleomycin induced Streaky Pigmentation and Scleroderma
【24h】

A Case of Bleomycin induced Streaky Pigmentation and Scleroderma

机译:博来霉素致斑纹色素沉着和硬皮病一例

获取原文

摘要

Bleomycin, a tumoricidal antibiotic agent, may produce unusual cutaneous manifestations such as pigmentation scleroderma, and gangrene. We report a case of the development of linear streaky pigmentation and cutaneous scleroderma in a patient treated with bleomycin for choriocarcinoma of undescented testis. The patient was 45-year-old male presented with linear brown and slate gray streaking over the trunk and extremities after three cycles of chemotherapy(bleomycin, etoposide, cisplatine). After the fourth cycle of the same chemotherapy, 18 weeks after initiation of bleomycin, the development of cutaneous scleroderma-like conditions was observed involving the same sites. Histopathologic examination showed increased basal pigmentation and thick collagen bundles through the entire dermis, extending to the subcutis. Herein, we describe a case of streaky pigmentation and scleroderma in association with bleomycin anticancer chemotherapy simultaneously in a patient.
机译:博来霉素是一种具有杀伤力的抗生素,可能产生异常的皮肤表现,例如色素沉着性硬皮病和坏疽。我们报道了一例用博来霉素治疗睾丸绒毛膜绒毛膜绒毛癌的患者出现线性条纹状色素沉着和皮肤硬皮病的情况。该患者为45岁的男性,经过三个周期的化疗(博来霉素,依托泊苷,顺铂)治疗后,躯干和四肢呈棕色和灰白色的线性条纹。在相同化学疗法的第四个周期后,博来霉素启动后18周,观察到涉及相同部位的皮肤硬皮病状的发展。组织病理学检查显示,整个真皮层基底色素沉着增加,胶原蛋白束增厚,延伸至皮下组织。在本文中,我们描述了同时伴有博莱霉素抗癌化学疗法的斑纹状色素沉着和硬皮病的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号